With 2.25 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.89 million shares. During the session, the Software – Infrastructure company that operates in wider Technology sector, reached to the highest price of $34.34 whereas the lowest price it dropped to was $34.24. The 52-week range on HCP shows that it touched its highest point at $34.40 and its lowest point at $20.89 during that stretch. It currently has a 1-year price target of $35.00. Beta for the stock currently stands at 1.19.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HCP was up-trending over the past week, with a rise of 0.32%, but this was up by 2.05% over a month. Three-month performance surged to 1.33% while six-month performance rose 2.85%. The stock gained 57.07% in the past year, while it has gained 0.32% so far this year. A look at the trailing 12-month EPS for HCP yields -0.61 with Next year EPS estimates of 0.48. For the next quarter, that number is 0.10. This implies an EPS growth rate of 537.50% for this year and 36.33% for next year.
Float and Shares Shorts:
At present, 161.39 million HCP shares are outstanding with a float of 153.13 million shares on hand for trading. On 2024-11-15, short shares totaled 9.87 million, which was 486.99997 higher than short shares on 1728950400. In addition to Mr. David McJannet as the firm’s CEO & Chairman of the Board, Mr. Armon Dadgar serves as its Co-Founder, CTO & Director.
Institutional Ownership:
Through their ownership of 0.81848 of HCP’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-07-31, HCP reported revenue of $173389000.0 and operating income of -$29882000.0. The EBITDA in the recently reported quarter was -$26411000.0 and diluted EPS was -$0.06.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HCP since 8 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 6 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With HCP analysts setting a high price target of 35.0 and a low target of 34.0, the average target price over the next 12 months is 34.85714. Based on these targets, HCP could surge 1.98% to reach the target high and fall by -0.93% to reach the target low. Reaching the average price target will result in a growth of 1.57% from current levels.
Analysts have provided yearly estimates in a range of -$0.11845 being high and -$0.13819 being low. For HCP, this leads to a yearly average estimate of -$0.12832. Based on analyst estimates, the high estimate for the next quarter is $0.14 and the low estimate is $0.04. The average estimate for the next quarter is thus $0.08.
